BenBedPhar Training School 2023

NRF2 in noncommunicable diseases: from bench to bedside


One of the most relevant COST tools is the implementation of training schools. Three training schools will be organized by BebBedPhar as part of our “capacity building objectives”. The end goal is to promote a timely scientific community of NRF2 basic, pharmacological, and clinical researchers and entrepreneurs and to develop a “sense of belonging” to the EU scientific community. Our first training school is possible thanks to the positive and enthusiastic temper of Dr. Iveta Bernatova and the local organizers in Slovakia. They will make this training school a very successful vehicle for multidisciplinary training and international interaction of trainers and trainees.

Local Organizers.

Iveta Bernátová, head of the Local Organizing Committee (Action Management Committee member)

Senior researcher, Centre of Experi- mental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia

Miroslava Kvandová

Post-doc, Centre of Experi- mental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia

Peter Bališ

Researcher, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia

Michal Kluknavský

Post-doc, Centre of Experi- mental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia

Andrea Mičurová

PhD. Student, Centre of Experi- mental Medicine, Slovak Academy of Sciences, Bra- tislava, Slovakia


The Training School has a capacity for 40 trainees of which BenBedPhar will defray registration, the cost of travel and allowance (which will cover accommodation, catering and short-distance travel) for 21 trainees. The selection of trainees will be made among the PhD. students and young researchers participating in BenBedPhar project, considering quality of the submitted abstract and gender and geographical balance.

Trainees participating on their own will cover registration fee 100€, travel expenses and all other expenses listed below by themselves.

How to register?

We kindly ask all trainees to register via the Registration form which will be available online in this link or using this QR code with the password that will be announced to participants whose abstracts have been accepted for presentation. 

Registration will be open from March 15, 2023 to April 15, 2023.

Deadline for the second call for abstract submission is April 28, 2023.
Decisions will be announced by May 10, 2023.

Registration for abstracts that have been accepted for presentation will be open from March 30 to May 20, 2023.

Cancelation of participation

If you have to cancel your participation, please, inform the local organizers as soon as possible by email to

The registration fee will be returned, with a reduction necessary for the bank fees, if cancelation is made before June 15, 2023.

Abstracts Submission

Please, submit the abstract and short description of your CV and research interests by email to and

Deadline for abstract submission is March 10, 2023
Decision will be announced by March 15, 2023

The Abstract form is at the end of this Announcement. The length of the CV and ab stract sections may vary, but please do not exceed the maximum length of one page.

Invited Trainers

Antonio Cuadrado

Department of Biochemistry, Medical College, Autonomous University of Madrid, Madrid, Spain.

Gina Manda

Radiobiology Laboratory, Victor Babes National Institute of Pathology, Bucharest, Romania

Albena T. Dinkova-Kostova

Division of Cellular and Systems Medicine, University of Dundee School of Medicine, United Kingdom

Anna Grochot-Przeczek

Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland,

Manuela G. Lopez

Department of Pharmacology, Medical School and Institute Teofilo Hernando. Autonomous University of Madrid, Spain

Ioannis Trougakos

Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, 15784, Greece

Iveta Bernatova

Department of Experimental Hypertension, Institute of Normal and Pathological Physiolo- gy, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia


COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

BenBedPhar CA20121.

Action details.

Grant Holder: Universidad Autónoma de Madrid
Start of Action: 19 October, 2021
End of Action: 18 October, 2025
Entry into force: DATE HERE
CSO approval date: 25 May 2021
Action email: